Aditxt Announces Closing of $20.0 Million Public Offering
20.09.2022 - Aditxt, Inc., (Nasdaq: ADTX) (the “Company” or “Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public ...
Source: wallstreet-online.de